FRANKLIN LAKES, N.J. — BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced that Shana Neal has been appointed chief people officer, effective April 4, 2022. Neal, who held HR leadership positions at BD from 2005 to 2018, will oversee BD’s Human Resources, Communications and Social Investing functions globally, […]

WALTHAM, Mass. — Thermo Fisher Scientific Inc. (NYSE:TMO), the world leader in serving science, today announced Ruby Chandy has been elected to its board of directors, effective March 1, 2022. Ms. Chandy’s appointment will bring the total number of Thermo Fisher board members to 13. Ms. Chandy was the president of the Industrial Division of […]

London, UK – UK genomics company, RevoluGen Ltd. (RevoluGen or the Company), today announces Dr Annalisa Jenkins, MBBS, FRCP, as Chair of the Board of Directors. Dr Jenkins brings over 30 years of global industry experience to RevoluGen’s board, with expertise in scientific research, genomics, regulatory approval and healthcare systems. She is currently a board […]

MENLO PARK, Calif. — PacBio (Nasdaq: PACB), a leading developer of high-quality, highly accurate sequencing platforms, welcomes Michael Eberle, Ph.D., as Vice President of Computational Biology. Michael will be responsible for leading the company’s bioinformatics and data sciences program to enhance PacBio’s genomic analysis offerings. Michael is a genomics industry veteran with more than 20 years […]

CINCINNATI, Ohio — Meridian Bioscience, Inc. (NASDAQ: VIVO), a leading global provider of diagnostic testing solutions and life science raw materials, announced today that Andy Kitzmiller joined Meridian Bioscience as Executive Vice President and Chief Financial Officer, reporting directly to CEO Jack Kenny. He will oversee the global finance organization and financial activities, including accounting […]

Element Biosciences, developer of a new and disruptive DNA sequencing platform, today announced the appointment of Shawn Levy, Ph.D., as Senior Vice President of Applications and Scientific Affairs. A world-renowned pioneer in genomics research, Dr. Levy brings more than 20 years of in-depth knowledge to support Element’s growth and strategic plans for its first sequencing platform, AVITI™, […]

Founder and Executive Chairman of the Board to Advance Quantum-Si’s Protein Sequencing Technology and Commercialization Strategy GUILFORD, Conn. –– Quantum-Si Incorporated (Nasdaq: QSI) (“Quantum-Si,” “QSI” or the “Company”), a life sciences company commercializing single molecule protein sequencing, today announced the appointment of Dr. Jonathan Rothberg, Founder and Executive Chairman of Quantum Si’s Board of Directors, as […]

SAN DIEGO — Bionano Genomics, Inc. (BNGO), pioneer of optical genome mapping (OGM) solutions on the Saphyr® system and provider of NxClinical™, the leading software solution for visualization, interpretation and reporting of genomic data, today announced that it has appointed Helene Klein as its chief people officer, further strengthening its leadership team. As the company expands, culture and […]

HORIBA, Ltd. (“the Company”) hereby announces that the board of directors’ meeting held on February 14th, 2022 passed a resolution to nominate the candidate for director of the Company. The candidate for director and the directors to be reelected will be officially assigned after the resolution at the 84th ordinary general meeting of shareholders (“the […]